Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2015
Phase I Trial of the Pan-PI3K Inhibitor Pilaralisib (SAR245408/XL147) in Patients with Chronic Lymphocytic Leukemia (CLL) or Relapsed/Refractory LymphomaJennifer R Brown, Matthew S Davids, Jordi Rodon, et al.Breast Cancer Research and Treatment|October 27, 2015
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitorKimberly Blackwell, Howard Burris, Patricia Gomez, et al.Clinical Pharmacology in Drug Development|March 21, 2023
Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model-informed Drug Development StrategyHamim Zahir, Ophelia Yin, Ching Hsu, et al.Leukemia & Lymphoma|October 11, 2014
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphomaKyriakos P Papadopoulos, Coumaran Egile, Rodrigo Ruiz-Soto, et al.JHEP Reports : Innovation in Hepatology|March 11, 2026
Diabetes and obesity reduce FIB-4 accuracy in MASLD referral pathwaysAbdel-Aziz Shaheen, Elizabeth Baguley, Mark G Swain, et al.The Oncologist|March 30, 2018
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid TumorsGerald Edelman, Jordi Rodon, Joanne Lager, et al.CMAJ Open|May 17, 2020
Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional studyAbdel Aziz Shaheen, Kiarash Riazi, Alexandra Medellin, et al.CJC Open|May 26, 2021
CREATE: A New Data Resource to Support Cardiac Precision HealthSeungwon Lee, Bing Li, Elliot A Martin, et al.Microbiology Spectrum|June 26, 2023
Gp05, a Prophage-Encoded Virulence Factor, Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular InfectionYi Li, Fengli Zhu, Adhar C Manna, et al.Journal of Cardiac Failure|April 19, 2020
Enhancing ICD-Code-Based Case Definition for Heart Failure Using Electronic Medical Record DataYuan Xu, Seungwon Lee, Elliot Martin, et al.Pageof 4